Zimmer Biomet Holdings, Inc (NYSE: ZBH) is a medical device company that designs, manufactures, and sells reconstructive orthopedic implants and related surgical products. Revenue is generated through transactional sales of implants and instruments to hospitals and surgical facilities, with surgeons and healthcare systems as the primary customers. The company operates across knees, hips, shoulders, elbows, and other joints, and competes in the global orthopedic reconstruction market. The 10-K filed 2026-02-20 (accession 000119312526059853) identifies competition, pricing pressures, dependence on new product development, and shifts in product category and regional sales mix as material business risks, consistent with a transactional implant business where product cycles and hospital contracting drive revenue. The filing also flags customer demand changes driven by demographic shifts as a demand driver, pointing to aging populations as a key end-market tailwind. Zimmer Biomet is incorporated in the United States and headquartered in Warsaw, Indiana.
Source: SEC 10-K, filed 2026-02-20
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies Peers: Abbott Laboratories ABIOMED INC Baxter International Inc Edwards Lifesciences Corp Dexcom Inc HOLOGIC INC IDEXX Laboratories Inc Insulet Corp Resmed Inc Teleflex Inc
Loading...